 |
|
|
| |
Switching to Dolutegravir/Lamivudine (DTG/3TC) Is Non-inferior to Continuing Tenofovir Alafenamide (TAF)-Based Regimens at Week 196: TANGO Subgroup Analyses
|
| |
| |
IAS 2023 jut 25
Don E. Smith,1 Jean-Pierre Routy,2 Stefan Scholten,3 Julián Olalla Sierra,4 Mounir Ait-Khaled,5 Ruolan Wang,6 Parminder Saggu,7 Riya Moodley,5 Bryn Jones5
1Albion Centre, Sydney, Australia; 2McGill University Health Centre, Montreal, QC, Canada; 3Praxis Hohenstaufenring, Cologne, Germany; 4Hospital Costa del Sol, Marbella, Spain; 5ViiV Healthcare, Brentford, UK; 6ViiV Healthcare, Durham, NC, USA; 7GSK, Brentford, UK
|
| |
|
|
|
|
|
